Learn More
BACKGROUND The treatment of HBeAg-negative chronic hepatitis B (CHB) is considered to be open-ended, with no guidelines for treatment cessation. AIM To evaluate biochemical and virological relapse(More)
BACKGROUND Interferon-based therapy induces changes in viral dynamics in chronic hepatitis C (CHC) patients. AIMS The aim of this study was to assess early hepatitis C virus (HCV)-RNA changes and(More)